Clincosm LogoSign in Get a demo

Mantle Cell Lymphoma (MCL)

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
  • Routine care as per site standard.
  • (no location specified)
Sep 15, 2023

Mantle Cell Lymphoma (MCL) Trial in Australia, Canada, United States (Acalabrutinib, Venetoclax, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma (MCL)
  • Duarte, California
  • +11 more
Jul 17, 2023

Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing

Recruiting
  • Relapsed or Refractory B-cell Lymphoma
  • +6 more
  • Beijing, China
    Beijing Cancer Hospital
Feb 6, 2023

Mantle Cell Lymphoma (MCL) Trial in China (LP-168)

Not yet recruiting
  • Mantle Cell Lymphoma (MCL)
  • Hefei, Anhui, China
  • +29 more
Feb 7, 2023

Aggressive B-Cell Non-Hodgkin's Lymphoma, Aggressive B-Cell NHL, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial

Not yet recruiting
  • Aggressive B-Cell Non-Hodgkin's Lymphoma
  • +4 more
  • (no location specified)
Dec 16, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +7 more
  • Manchester, United Kingdom
  • +2 more
Aug 11, 2022

Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL) Trial in United States (voruciclib

Recruiting
  • Follicular Lymphoma (FL)
  • +6 more
  • voruciclib monotherapy
  • voruciclib and venetoclax
  • Duarte, California
  • +10 more
Aug 10, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Duarte, California
  • +10 more
Jul 14, 2022

Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type DLBCL (ABC-DLBCL), Mantle Cell Lymphoma (MCL) Trial in Indianapolis, Spokane

Recruiting
  • Non-Hodgkin's Lymphoma (NHL)
  • +4 more
  • Indianapolis, Indiana
  • +1 more
Jul 12, 2022

Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day

Recruiting
  • Non Hodgkin Lymphoma (NHL)
  • +6 more
  • 8/12-Day Production of Car-T Cells
  • +2 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin and Froedtert Hospital
Jul 1, 2022

Ibrutinib Combined With Bendamustine and Rituximab in Newly

Recruiting
  • Mantle Cell Lymphoma (MCL)
    • Beijing, Beijing, China
      Peking University Third Hospital
    May 31, 2022

    Mantle Cell Lymphoma (MCL) Trial in Japan (Ibrutinib, Venetoclax)

    Active, not recruiting
    • Mantle Cell Lymphoma (MCL)
    • Nagoya-shi, Aichi, Japan
    • +11 more
    Apr 4, 2022

    Diffuse Large B-cell Lymphoma(DLBCL), Mantle Cell Lymphoma (MCL), Follicular Lymphoma (FL) Trial in Worldwide (AMG 562)

    Completed
    • Diffuse Large B-cell Lymphoma(DLBCL)
    • +2 more
    • AMG 562
    • Duarte, California
    • +11 more
    Feb 22, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +6 more
    • Tucson, Arizona
    • +23 more
    Dec 14, 2021

    Diffuse Large B Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL) Trial in France (Real-life

    Recruiting
    • Diffuse Large B Lymphoma (DLBCL)
    • +6 more
    • Real-life epidemiological platform of lymphoma in France
    • Arras, France
    • +36 more
    Jun 25, 2021

    CD5+ Relapsed/Refractory Hematopoietic Malignancies, Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL) Trial

    Not yet recruiting
    • CD5+ Relapsed/Refractory Hematopoietic Malignancies
    • +5 more
    • CT125A cells
    • Cyclophosphamide, fludarabine
    • (no location specified)
    Feb 19, 2021

    Lymphomas Non-Hodgkin's B-Cell, Diffuse Large B-cell Lymphoma (DLBCL), Primary Mediastinal B-cell Lymphoma (PMBCL) Trial in

    Recruiting
    • Lymphomas Non-Hodgkin's B-Cell
    • +5 more
    • WZTL002-1 (1928T2z CAR-T cells)
    • Cyclophosphamide and Fludarabine lymphodepleting chemotherapy
    • Wellington, New Zealand
      Wellington Hospital, Capital & Coast District Health Board
    Feb 18, 2020

    Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas

    Unknown status
    • Follicular Lymphoma (FL)
    • +2 more
      • London, Surrey, United Kingdom
      • +1 more
      Aug 25, 2017